Titel

Merkliste
1 Ergebnisse

P.025 Efficacy and safety results of the avalglucosidase al..:

Tarnopolsky, M ; Attarian, S ; Borges, J...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 48 (2021) s3 - p. S27-S27 , 2021

Link: https://doi.org/10.1017/cjn.2021.307

RT Journal
T1 <Title>P.025 Efficacy and safety results of the avalglucosidase alfa phase 3COMET trial in participants with late-onset Pompe disease (LOPD)</Title>

UL https://suche.suub.uni-bremen.de/peid=cr-10.1017_cjn.2021.307&Exemplar=1&LAN=DE
				
A1 Tarnopolsky, M
A1 Attarian, S
A1 Borges, J
A1 Bouhour, F
A1 Choi, Y
A1 Clemens, P
A1 Day, J
A1 Díaz-Manera, J
A1 Erdem-Ozdamar, S
A1 Goker-Alpan, O
A1 Illarioshkin, S
A1 Kishnani, PS
A1 Kostera-Pruszczyk, A
A1 Kushlaf, H
A1 Ladha, S
A1 Mozaffar, T
A1 Roberts, M
A1 Straub, V
A1 Toscano, A
A1 van der Ploeg, AT
A1 An Haack, K
A1 Hug, C
A1 Huynh-Ba, O
A1 Johnson, J
A1 Zhou, T
A1 Dimachkie, MM
A1 Schoser, B
A1 on behalf of theCOMET Study Group ()
PB Cambridge University Press (CUP)
YR 2021
SN 0317-1671
SN 2057-0155
JF Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
VO 48
IS s3
SP S27
OP S27
LK http://dx.doi.org/https://doi.org/10.1017/cjn.2021.307
DO https://doi.org/10.1017/cjn.2021.307
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)